Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PILOS-AF
NCT06212674Phase 4Recruiting
- Sponsor
- Medical University of Silesia
- Start
- Oct 2025
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in ischemic stroke and Atrial fibrillation (AFib) (3 arms), sponsored by Medical University of Silesia. Primary endpoint: Composite of cardiovascular deaths, ischemic stroke, transient ischemic attack (TIA), systemic embolism or major bleeding unrelated to the procedure at 12 months. Started Oct 2025; status: recruiting.
02
Conditions
ischemic strokeAtrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06212674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06212674.